AA
CTIC

Ancora Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Ancora Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed – – 2388
2021
Q2 		$0 Hold
1
– – ﹤0.01% 2206
2021
Q1 		$0 Hold
1
– – ﹤0.01% 1899
2020
Q4 		$0 Hold
1
– – ﹤0.01% 1611
2020
Q3 		$0 Hold
1
– – ﹤0.01% 1532
2020
Q2 		$0 Hold
1
– – ﹤0.01% 1552
2020
Q1 		$0 Hold
1
– – ﹤0.01% 1582
2019
Q4 		$0 Buy
+1
New +$1 ﹤0.01% 1408
2018
Q4 		– Sell
-1
Closed – – 1359
2018
Q3 		$0 Buy
+1
New +$2 ﹤0.01% 1371
2014
Q2 		– Sell
-5,500
Closed -$187K – 525
2014
Q1 		$187K Buy
5,500
+4,100
+293% +$140K 0.03% 410
2013
Q4 		$27K Buy
+1,400
New +$25.5K ﹤0.01% 421

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GTC
Ghost Tree Capital New York $276M AUM 70.11% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return